Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder

NCT: NCT06782763 · COMPLETED

NCT IDNCT06782763
StatusCOMPLETED
Start Date2024-12-20
Completion2025-09-01

Brief Summary

1. To clarify the efficacy and safety of task-based repetitive transcranial magnetic stimulation (rTMS) on cognitive function in patients with stable bipolar disorder. 2. To analyze the therapeutic mechanism of transcranial magnetic stimulation based on magnetic resonance imaging and explore the abnormal regulation mechanism of cognitive neural circuits.

Frequently Asked Questions

What is Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder?

Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder is a clinical trial registered under NCT06782763. Current status: COMPLETED.

What is the status of NCT06782763?

The current status of NCT06782763 (Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder) is: COMPLETED.

When did Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder start?

Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder started on 2024-12-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑